Pharmacology of hallucinations induced by long-term drug therapy
- 1 April 1982
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 139 (4) , 494-497
- https://doi.org/10.1176/ajp.139.4.494
Abstract
Patients [20] with Parkinson''s disease and prominent hallucinations related to dopaminergic or anticholinergic therapy were studied. The character of the hallucinations appeared to be distinct from the classic description of either acute anticholinergic or acute aminergic hallucinatory states. Manipulation of either kind of drug could precipitate or relieve hallucinations in a given patient, which suggests that the dopaminergic/cholinergic systems are reciprocally active in the pathophysiology of long-term drug-induced hallucinatory states in this population.This publication has 7 references indexed in Scilit:
- Levodopa-induced psychosis: a kindling phenomenonAmerican Journal of Psychiatry, 1978
- Levodopa‐Induced dopamine receptor hypersensitivityAnnals of Neurology, 1977
- Mental symptoms in Parkinson's disease during chronic treatment with levodopaNeurology, 1976
- Cholinergic and dopaminergic mechanisms in Huntington's choreaLife Sciences, 1971
- Cholinergic-Anticholinergic Antagonism in ParkinsonismArchives of Neurology, 1967
- ATROPINE POISONING: REPORT OF TWO CASESAnnals of Internal Medicine, 1956
- EFFECTS OF MESCALINE AND LYSERGIC ACID (d-LSD-25)American Journal of Psychiatry, 1952